Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

  • Lagos, Nigeria
  • Info@bhluemountain.com
  • Office Hours: 8:00 AM – 5:00 PM Mon - Fri
  • September 19 2023

One year after resigning as 54Gene CEO, Abasi Ene-Obong is back in the arena

Abasi Ene-Obong, former co-founder and CEO of 54gene has launched a new startup—Syndicate Bio. On Monday, Abasi Ene-Obong, former CEO of Nigerian health and biotech startup 54gene, announced the launch of his new venture, Syndicate Bio. Per his LinkedIn post, Syndicate Bio will drive genomics and precision medicine initiatives across the world’s most diverse regions, starting from Africa. “After a few months in stealth mode, I am happy to say that we have started Syndicate Bio to empower inclusive advancements in global genomics science.” Jumi Popoola and Estelle Dogbo will serve as the chief scientific officer and chief operating officer of Syndicate Bio.  According to Ene-Obong, Syndicate Bio uses collaboration with governments, pharma companies, academia, and other stakeholders to drive local precision medicine impact while creating powerful datasets that can be used for drug discovery and development.“In the coming months, we will be sharing some of the great strides made in furtherance of our vision and mission,” the post concluded. Ene-Obong founded 54gene in 2019 to address the shortage of African genetic material in pharmaceutical research. He stepped down in October 2022 following a challenging year for the company. The company saw its valuation slashed by over $100 million and eventually laid off 30% of its workforce. While the reason for his resignation was not disclosed, one publication insinuated that it was one of the conditions for investors to provide additional funding to the company. 

Read More